| Application no. and date | 17883800.9 (espacenet) (Federated) (European Patent Register), 20171221 | | Patent/reg. no. and date | DK/EP 3558369, 20250326 | | Publication date | 20191030 | | Priority no. and date | US 201662437143 P, 20161221 | | EP pub. no. and date |
EP 3558369 20191030 | | Effective date | | | Applicant/owner | Cephalon LLC, 145 Brandywine Parkway
West Chester, PA 19380, US | | Applicant ref. no. | V488782DK00 | | Inventor | POLLARD, Matthew, 60 Summerland Place,
Pullenvale QLD 4069, AU,
DOYLE, Anthony Gerard, Teva Pharmaceuticals Austrakia Pty Ltd.,
37 Epping Road,
Macquarie Park NSW 2113, AU,
POULTON, Lynn Dorothy, Teva Pharmaceutical Australia pty Ltd.,
37 Epping Road
Macquarie Park NSW 2113, AU,
CLARKE, Adam William, Teva Pharmaceutical Australia Pty Ltd.,
37 Epping Road,
Macquarie Park NSW 2113,, AU,
LAINE, David Jose Simon, Teva Pharmaceutical Australia Pty Ltd.,
37 Epping Road,
Macquarie Park NSW 2113, AU | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 19/02 (2006.01) , C07K 16/24 (2006.01) , G01N 33/53 (2006.01) | | Title | ANTISTOFFER, DER SPECIFIKT BINDER TIL HUMANT IL-15, OG ANVENDELSE HERAF | | Int. application no. | US2017067917 | | Int. publication no. | WO2018119246 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
